Windtree Therapeutics, trading under the ticker WINT, has revealed a strategic alliance with Kraken to enhance its BNBCryptoTreasury Strategy. This collaboration will allow Kraken to deliver custody, trading, and over-the-counter services. The agreement, currently formalized in a term sheet, awaits finalization through a definitive agreement, pending shareholder approval of Windtree’s earlier securities purchase arrangement. This partnership includes potential future subscriptions worth up to $140 million, spearheaded by Build and Build Corp.
Through this collaboration, Windtree aims to capitalize on Kraken’s prowess in security, liquidity, and digital asset management, aligning with its BNB-focused treasury aims. The company anticipates that this move will improve access to the Binance ecosystem for both retail and institutional investors, reinforcing its position in the digital asset market.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 1 analysts, the average target price for Windtree Therapeutics Inc (WINT, Financial) is $350.00 with a high estimate of $350.00 and a low estimate of $350.00. The average target implies an upside of 35,253.54% from the current price of $0.99. More detailed estimate data can be found on the Windtree Therapeutics Inc (WINT) Forecast page.
Based on the consensus recommendation from 1 brokerage firms, Windtree Therapeutics Inc's (WINT, Financial) average brokerage recommendation is currently 3.0, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
